Pharmaceutical News

RSS

Study highlights need for interventions to improve statin use among older adults

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

7 Nov 2018

New AI technology can potentially reduce bottlenecks in drug research

Researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.

7 Nov 2018

Study finds rapid increase in overdose deaths involving amphetamines and methamphetamines

The number of overdose deaths involving methamphetamines and amphetamines in the state of Ohio increased more than 5,000 percent over the course of eight years, according to data collected by the Ohio Alliance for Innovation in Population Health.

7 Nov 2018

New study supports use of antibiotic prophylaxis in patients undergoing invasive dental treatment

New research has revealed the impact a change in US guidelines had on the prescribing of antibiotic prophylaxis to prevent a life-threatening heart condition infective endocarditis in patients before undergoing invasive dental treatment.

5 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Experts identify barriers to using stroke-preventing anticoagulants in Canada

International guidelines recommend direct oral anticoagulants over warfarin to prevent stroke for most patients with atrial fibrillation.

5 Nov 2018

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry.

5 Nov 2018

Researchers observe cognitive changes in offspring of rats exposed to high cannabis doses

Washington State University researchers have seen cognitive changes in the offspring of rats exposed to heavy amounts of cannabis. Their work is one of the rare studies to look at the effects of cannabis during pregnancy.

5 Nov 2018

New heart drug spotlights troubling trends in drug marketing

At the end of September, Amarin Corp. teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease.

2 Nov 2018

New way of identifying potential cancer drugs could streamline development of therapies

A new way of identifying potential cancer drugs could streamline the development of therapies, following a discovery by scientists.

2 Nov 2018

Wellspring celebrates grand opening of its compounding pharmacy division

Wellspring celebrated its compounding pharmacy division's grand opening with a ribbon cutting attended by over 60 guests, including Berkeley Mayor Jesse Arreguín, on Tuesday, October 30th at its new location.

2 Nov 2018

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.

2 Nov 2018

Drexel University-led project to study how California's's changing cannabis laws impact public health

A Drexel University-led research project aimed at studying the health and behavioral effects of medical marijuana use for young adults living in Los Angeles has been renewed for another five years.

2 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Drug combination not more effective in improving depression than single antidepressant

Psychiatrists and GPs increasingly combine mirtazapine with an SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin-noradenaline reuptake inhibitor) antidepressant for patients whose depression does not respond to a single antidepressant.

1 Nov 2018

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL International Corporation has announced a new China Advisory Service to help global biopharmaceutical companies participate in the growing, yet complex market opportunity within China.

From Parexel 1 Nov 2018

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

The Indiana University Philanthropic Venture Fund, which provides capital to faculty, students, alumni and staff at all IU campuses to help them further develop their research and innovations into startup companies, has committed to invest $500,000 in Indianapolis-based NERx Biosciences Inc. as part of a $2.2 million bridge round.

1 Nov 2018

Doctors find no association between autism and drugs taken during pregnancy

A new study has found that babies exposed to medications in the womb are at no more risk of developing autism than babies who are not exposed to any drugs.

31 Oct 2018

Study finds link between early life antibiotic exposure and weight gain in children

A pioneering study conducted within a nationwide network, the National Patient Centered Clinical Research Network, finds that antibiotic use at <24 months of age was associated with slightly higher body weight at 5 years of age.

31 Oct 2018

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.

31 Oct 2018

Pharmaceutical News

Study highlights need for interventions to improve statin use among older adults

New AI technology can potentially reduce bottlenecks in drug research

Study finds rapid increase in overdose deaths involving amphetamines and methamphetamines

New study supports use of antibiotic prophylaxis in patients undergoing invasive dental treatment

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Experts identify barriers to using stroke-preventing anticoagulants in Canada

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Researchers observe cognitive changes in offspring of rats exposed to high cannabis doses

New heart drug spotlights troubling trends in drug marketing

New way of identifying potential cancer drugs could streamline development of therapies

Wellspring celebrates grand opening of its compounding pharmacy division

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

Drexel University-led project to study how California's's changing cannabis laws impact public health

Researchers find a class of drug that could be promising treatment for uveitis

Drug combination not more effective in improving depression than single antidepressant

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

Doctors find no association between autism and drugs taken during pregnancy

Study finds link between early life antibiotic exposure and weight gain in children

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Latest News